Baxter International Inc (BAX) : Destination Wealth Management scooped up 15,477 additional shares in Baxter International Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 200,047 shares of Baxter International Inc which is valued at $9,006,116.Baxter International Inc makes up approximately 0.71% of Destination Wealth Management’s portfolio.
Other Hedge Funds, Including , Euclid Advisors sold out all of its stake in BAX during the most recent quarter. The investment firm sold 39,342 shares of BAX which is valued $1,771,177.Bb&t Securities boosted its stake in BAX in the latest quarter, The investment management firm added 35,227 additional shares and now holds a total of 422,402 shares of Baxter International Inc which is valued at $19,683,933. Baxter International Inc makes up approx 0.30% of Bb&t Securities’s portfolio. America First Investment Advisors added BAX to its portfolio by purchasing 59 company shares during the most recent quarter which is valued at $2,749.Equity Investment Corpga reduced its stake in BAX by selling 96,444 shares or 7.48% in the most recent quarter. The Hedge Fund company now holds 1,193,398 shares of BAX which is valued at $55,958,432. Baxter International Inc makes up approx 1.82% of Equity Investment Corpga’s portfolio. Factory Mutual Insurance Co sold out all of its stake in BAX during the most recent quarter. The investment firm sold 39,700 shares of BAX which is valued $1,883,368.
Baxter International Inc closed down -0.12 points or -0.25% at $46.98 with 23,99,253 shares getting traded on Monday. Post opening the session at $47.1, the shares hit an intraday low of $46.8 and an intraday high of $47.19 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Baxter International Inc reported $0.56 EPS for the quarter, beating the analyst consensus estimate by $ 0.11 according to the earnings call on Oct 25, 2016. Analyst had a consensus of $0.45. The company had revenue of $2558.00 million for the quarter, compared to analysts expectations of $2548.94 million. The company’s revenue was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.41 EPS.
Investors should note that on Nov 8, 2016, Baxter International Inc announced a cash dividend of $0.1300. The company’s management has announced Nov 30, 2016 as the ex-dividend date and fixed the record date on Dec 2, 2016. The payable date has been fixed on Jan 3, 2017.
Many Wall Street Analysts have commented on Baxter International Inc. Company shares were Reiterated by RBC Capital Mkts on Oct 26, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 55 from a previous price target of $50 .Baxter International Inc was Initiated by Wells Fargo to “Outperform” on Oct 13, 2016.
Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment which include three commercial franchises: Hemophilia BioTherapeutics and BioSurgery and Medical Products segment which include four commercial franchises: Fluid Systems Renal Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies alpha-1 antitrypsin deficiency burns and shock and other chronic and acute blood-related conditions and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets premixed drugs and drug-reconstitution systems pre-filled vials and syringes for injectable drugs IV nutrition products infusion pumps and inhalation anesthetics. Its products are used in hospitals kidney dialysis centers and nursing homes among others.